Navigation Links
Irene Hegeman Richard, MD, Appointed Senior Medical Advisor to The Michael J. Fox Foundation
Date:11/29/2007

NEW YORK, Nov. 29 /PRNewswire-USNewswire/ -- In keeping with The Michael J. Fox Foundation's mission to accelerate scientific breakthroughs that can transform the lives of people with Parkinson's disease, the Foundation today announced the appointment of Irene Hegeman Richard, MD, to the newly created role of Senior Medical Advisor. This appointment formalizes the role of Dr. Richard, who is associate professor of neurology and psychiatry at the University of Rochester School of Medicine and Dentistry, in helping to inform and develop MJFF's clinical agenda.

Dr. Richard brings experience in running large-scale Parkinson's trials and is familiar with the challenges facing this research area. Formalizing her role as advisor to the Foundation will help ensure that MJFF's increasing involvement in clinical trials, including trial design and regulatory issues, is as efficient and targeted as possible. She will also provide important feedback on pre-clinical experimental design, helping to ensure that all studies funded by MJFF --- not only those requiring the active involvement of patients --- are designed with potential clinical issues in mind.

"Irene's clinical research perspective complements the scientific expertise of Gene Johnson, PhD, MJFF's chief scientific advisor, and her input will be a boon to our research staff and advisors in continually raising the bar on the patient-relevant outcomes we expect from every project we fund," said Katie Hood, interim CEO of The Michael J. Fox Foundation. "Additionally, as a clinician with an active neurology practice, Irene has a deep understanding of the challenges faced every day by people living with PD --- something the Foundation values deeply, since patients are at the center of every activity we undertake."

Dr. Richard has served on the Foundation's SAB since 2006. She also has been a member of the review committee for the Foundation's annual Clinical Discovery Program, which funds high-impact clinical projects in PD, since the program was first launched in 2004, and has played a key role in continually refining its specific criteria for patient-relevant grant selection. Additionally, she has frequently spoken to MJFF friends and supporters at the Foundation's Research Roundtable events across the country.

At the University of Rochester, Dr. Richard provides neurological care for people living with PD and runs a research program focused on the psychiatric aspects of the illness. She is currently leading an NIH-funded multi-center clinical trial evaluating the treatment of depression in PD. She has given lectures and chaired workshops and symposia at national meetings including the American Academy of Neurology and The World Parkinson Congress.

"As a grant reviewer for the Foundation and a member of its Scientific Advisory Board, I've been impressed by The Michael J. Fox Foundation's extraordinary commitment to speeding scientific solutions to the clinic and patients --- a commitment I share," said Dr. Richard. "The Foundation understands that it's never too early in the drug development process to think clinically, and I'm thrilled to take on formal responsibility for working with its staff and advisors to continually improve our ability to do this across the board."

About The Michael J. Fox Foundation

Founded in 2000, The Michael J. Fox Foundation for Parkinson's Research is dedicated to ensuring the development of a cure for Parkinson's disease within this decade through an aggressively funded research agenda. The Foundation has funded over $98 million in research to date, either directly or through partnerships.


'/>"/>
SOURCE Michael J. Fox Foundation
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Dr. Allen Woolf Appointed Chief Medical Officer For CIGNA Group Insurance
2. William Moore Appointed to IRIDEX Board of Directors
3. Roy Jakobs Appointed Elsevier Managing Director, A&G Sales and Customer Marketing
4. Katie Hood Appointed Interim Chief Executive Officer of Michael J. Fox Foundation
5. Theodore A. Boutacoff Appointed President & CEO of IRIDEX
6. James B. Hawkins Appointed to IRIDEX Board of Directors
7. Bryan R. Rogers Appointed President of Far West Division
8. Catholic Health Association Disappointed by Failure to Override SCHIP Veto
9. Steven M. Safyer, MD, Appointed President and CEO of Montefiore Medical Center
10. Dr. Warren Wasiewski Appointed Chief Medical Officer of Neurobiological Technologies, Inc.
11. Oral Health a Matter of Life and Death for Seniors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... ... advisory services for healthcare compliance program management, will showcase a range of technology ... Association for Assisted Living (NCAL) Convention and Expo to be held October 14–18, ...
(Date:10/12/2017)... CITY, Fla. (PRWEB) , ... October 12, 2017 , ... ... cold therapy products, announced today the introduction of an innovative new design of the ... multipurpose pad so you get maximum comfort while controlling your pain while using cold ...
(Date:10/12/2017)... ... October 12, 2017 , ... Dr. Parsa ... contributed a medical article to the newly revamped Cosmetic Town journal ... the hair transplant procedure known as Follicular Unit Extraction (FUE). , ...
(Date:10/12/2017)... ... 12, 2017 , ... Women-owned and Grand Rapids-based workplace wellness ... in Wellness® by Best and Brightest. OnSite Wellness will be honored at the ... 7:30 a.m. to 2 p.m. at the Henry Autograph Collection Hotel, located at ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... of California Berkeley, and other leading institutions in announcing the launch of the ... to change the way animals are raised for food. , Founding members of ...
Breaking Medicine News(10 mins):
(Date:10/2/2017)... 2017 Diplomat Pharmacy, Inc. (NYSE: ... Consulting, LLC , and named its founder as Diplomat,s ... Tennessee , will operate under Diplomat ... service offerings for health care partners to include IT ... "In an interoperable world, technology delivers comprehensive ...
(Date:10/2/2017)...  AllianceRx Walgreens Prime, the combined central specialty pharmacy ... benefit manager Prime Therapeutics LLC (Prime), today officially began ... unveiling of new signage at its headquarters in ... a few other company-owned facilities across the country. This ... of whom will begin to see the AllianceRx Walgreens ...
(Date:10/2/2017)... The Rebound mobile app is poised to become ... tide of prescription drug addiction. The app empowers users to ... stepping down their dosage in a safe, controlled manner while ... the first 100,000 people to sign up will enjoy 3 ... ...
Breaking Medicine Technology: